Inhibrx Biosciences, Inc. Cash Flow Quality Index
Inhibrx Biosciences, Inc. cash flow quality index. Inhibrx Biosciences, Inc. (INBX) has a Cash Flow Quality Index of -0.03x as of June 2024. Operating cash flow of $-57.36 Million is below net income of $1.83 Billion, suggesting accrual-heavy earnings not yet converted to cash. See INBX financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Inhibrx Biosciences, Inc. (2024–2024)
Cash flow quality index of Inhibrx Biosciences, Inc. from 2024 to 2024. Historical Cash Flow Quality Index for Inhibrx Biosciences, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Inhibrx Biosciences, Inc. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Inhibrx Biosciences, Inc. Cash Flow Quality Index by Year (2024–2024)
Inhibrx Biosciences, Inc. cash flow quality index by year from 2024 to 2024. Year-by-year earnings quality comparison for Inhibrx Biosciences, Inc.. For the full cash flow conversion analysis, see how efficiently does Inhibrx Biosciences, Inc. generate cash.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.12x | $-194.41 Million | $1.69 Billion | — |